Published in Expert Opin Drug Metab Toxicol on June 01, 2006
PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics. Pharmacogenomics (2008) 1.27
The pregnane X receptor: from bench to bedside. Expert Opin Drug Metab Toxicol (2008) 1.24
New predictive models for blood-brain barrier permeability of drug-like molecules. Pharm Res (2008) 1.20
Functional evolution of the vitamin D and pregnane X receptors. BMC Evol Biol (2007) 1.17
Evolution of pharmacologic specificity in the pregnane X receptor. BMC Evol Biol (2008) 1.14
Nuclear receptor PXR, transcriptional circuits and metabolic relevance. Biochim Biophys Acta (2011) 1.10
The far and distal enhancers in the CYP3A4 gene co-ordinate the proximal promoter in responding similarly to the pregnane X receptor but differentially to hepatocyte nuclear factor-4alpha. Biochem J (2008) 1.01
The environmental estrogen, nonylphenol, activates the constitutive androstane receptor. Toxicol Sci (2007) 0.97
Evolution of promiscuous nuclear hormone receptors: LXR, FXR, VDR, PXR, and CAR. Mol Cell Endocrinol (2010) 0.97
An amphioxus orthologue of the estrogen receptor that does not bind estradiol: insights into estrogen receptor evolution. BMC Evol Biol (2008) 0.91
The evolution of farnesoid X, vitamin D, and pregnane X receptors: insights from the green-spotted pufferfish (Tetraodon nigriviridis) and other non-mammalian species. BMC Biochem (2011) 0.89
Synergistic activation of human pregnane X receptor by binary cocktails of pharmaceutical and environmental compounds. Nat Commun (2015) 0.78
In vivo activity and pharmacokinetics of nemorosone on pancreatic cancer xenografts. PLoS One (2013) 0.76
Evaluation of a novel PXR-knockout in HepaRG(™) cells. Pharmacol Res Perspect (2016) 0.75
The pregnane X receptor in tuberculosis therapeutics. Expert Opin Drug Metab Toxicol (2015) 0.75
Sequence and comparative analysis of the chicken genome provide unique perspectives on vertebrate evolution. Nature (2004) 21.40
Whole-genome shotgun assembly and analysis of the genome of Fugu rubripes. Science (2002) 20.59
Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics (1998) 11.25
The draft genome of Ciona intestinalis: insights into chordate and vertebrate origins. Science (2002) 11.11
Genome duplication in the teleost fish Tetraodon nigroviridis reveals the early vertebrate proto-karyotype. Nature (2004) 11.03
Statistical methods for detecting molecular adaptation. Trends Ecol Evol (2000) 10.10
Inferring nonneutral evolution from human-chimp-mouse orthologous gene trios. Science (2003) 9.20
Likelihood ratio tests for detecting positive selection and application to primate lysozyme evolution. Mol Biol Evol (1998) 8.74
Large-scale search for genes on which positive selection may operate. Mol Biol Evol (1996) 6.14
An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell (1998) 5.97
Genomewide comparison of DNA sequences between humans and chimpanzees. Am J Hum Genet (2002) 5.80
The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest (1998) 4.76
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci U S A (2001) 4.58
SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev (1998) 4.19
Vitamin D receptor as an intestinal bile acid sensor. Science (2002) 3.64
The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med (2001) 3.45
Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature (2000) 3.41
The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science (2001) 3.27
Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci U S A (1998) 3.24
Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature (1998) 3.23
Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem (2000) 3.23
The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev (2002) 2.95
Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol (2002) 2.94
An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci U S A (2001) 2.83
Maximum likelihood estimation on large phylogenies and analysis of adaptive evolution in human influenza virus A. J Mol Evol (2000) 2.78
The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell (2000) 2.77
The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol Endocrinol (2000) 2.74
Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem (1991) 2.70
St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci U S A (2000) 2.64
Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem (2001) 2.62
Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy. Am J Obstet Gynecol (2005) 2.51
Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc Natl Acad Sci U S A (2003) 2.46
Update: clinically significant cytochrome P-450 drug interactions. Pharmacotherapy (1998) 2.43
The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med (2000) 2.31
The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics (2001) 2.29
Aryl hydrocarbon receptors: diversity and evolution. Chem Biol Interact (2002) 2.27
Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog (1995) 2.25
Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev (2000) 2.15
Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution. Proc Natl Acad Sci U S A (2005) 2.12
Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis. Lancet (1989) 1.86
Comparative studies of bile salts, myxinol disulphate, the principal bile salt of hagfish (Myxinidae). Biochem J (1966) 1.81
Transporters and drug therapy: implications for drug disposition and disease. Clin Pharmacol Ther (2005) 1.81
Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. Drug Metab Dispos (2001) 1.70
Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem (2003) 1.69
Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors. Mol Endocrinol (2002) 1.67
Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J Biol Chem (2001) 1.67
Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proc Natl Acad Sci U S A (2002) 1.65
Detoxification of lithocholic acid, a toxic bile acid: relevance to drug hepatotoxicity. Drug Metab Rev (2004) 1.64
The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization. Mol Cell (2004) 1.61
Specific and overlapping functions of the nuclear hormone receptors CAR and PXR in xenobiotic response. Pharmacogenomics J (2002) 1.58
Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4. Drug Metab Dispos (2001) 1.58
Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor. J Mol Biol (2003) 1.57
Structural disorder in the complex of human pregnane X receptor and the macrolide antibiotic rifampicin. Mol Endocrinol (2005) 1.55
2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin. Biochemistry (2003) 1.55
A structural basis for constitutive activity in the human CAR/RXRalpha heterodimer. Mol Cell (2004) 1.51
Rat pregnane X receptor: molecular cloning, tissue distribution, and xenobiotic regulation. Arch Biochem Biophys (1999) 1.49
Comparative studies of bile salts. Bile salts of the lamprey Petromyzon marinus L. Biochem J (1969) 1.42
The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochim Biophys Acta (2003) 1.40
The constitutive androstane receptor and pregnane X receptor function coordinately to prevent bile acid-induced hepatotoxicity. J Biol Chem (2004) 1.38
Genomic analysis of the nuclear receptor family: new insights into structure, regulation, and evolution from the rat genome. Genome Res (2004) 1.38
Analysis of lamprey and hagfish genes reveals a complex history of gene duplications during early vertebrate evolution. Mol Biol Evol (2002) 1.37
Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. Mol Pharmacol (2005) 1.37
Isolation and culture of primary human hepatocytes. Methods Mol Biol (2005) 1.34
How many nuclear hormone receptors are there in the human genome? Trends Genet (2001) 1.34
Evolution of the pregnane x receptor: adaptation to cross-species differences in biliary bile salts. Mol Endocrinol (2005) 1.33
Induction of CYP2C genes in human hepatocytes in primary culture. Drug Metab Dispos (2001) 1.32
Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds. Curr Drug Metab (2006) 1.32
Human hepatocytes as a tool for studying toxicity and drug metabolism. Curr Drug Metab (2003) 1.29
Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor. Proc Natl Acad Sci U S A (2002) 1.28
Orphan nuclear receptors adopted by crystallography. Curr Opin Struct Biol (2005) 1.28
The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions. J Clin Pharmacol (1999) 1.28
The human CYP3A subfamily: practical considerations. Drug Metab Rev (2001) 1.26
The nuclear pregnane X receptor regulates xenobiotic detoxification. J Nutr (2003) 1.24
St John's wort, a herbal antidepressant, activates the steroid X receptor. J Endocrinol (2000) 1.21
Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling. Proc Natl Acad Sci U S A (2004) 1.20
Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands. Proc Natl Acad Sci U S A (2001) 1.20
The first completed genome sequence from a teleost fish (Fugu rubripes) adds significant diversity to the nuclear receptor superfamily. Nucleic Acids Res (2003) 1.20
Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis). J Med Chem (2002) 1.19
Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures. Drug Metab Dispos (2004) 1.19
Comparative studies of 'bile salts'. 18. The chemistry of cyprinol. Biochem J (1964) 1.19
Feed-forward regulation of bile acid detoxification by CYP3A4: studies in humanized transgenic mice. J Biol Chem (2003) 1.19
Hepatic levels of bile acids in end-stage chronic cholestatic liver disease. Clin Chim Acta (1996) 1.18
Substrates of human hepatic cytochrome P450 3A4. Toxicology (1995) 1.17
Evolutionary selection across the nuclear hormone receptor superfamily with a focus on the NR1I subfamily (vitamin D, pregnane X, and constitutive androstane receptors). Nucl Recept (2005) 1.17
Structure and function of the human nuclear xenobiotic receptor PXR. Curr Drug Metab (2005) 1.14
CYP3A4 induction by xenobiotics: biochemistry, experimental methods and impact on drug discovery and development. Curr Drug Metab (2004) 1.13
Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX. J Lipid Res (2001) 1.13
Use of the nuclear receptor PXR to predict drug interactions. Toxicology (2000) 1.12
Benzoate X receptors alpha and beta are pharmacologically distinct and do not function as xenobiotic receptors. J Biol Chem (2002) 1.11
Structure of the murine constitutive androstane receptor complexed to androstenol: a molecular basis for inverse agonism. Mol Cell (2004) 1.11
Vitamin E activates gene expression via the pregnane X receptor. Biochem Pharmacol (2003) 1.11
BXR, an embryonic orphan nuclear receptor activated by a novel class of endogenous benzoate metabolites. Genes Dev (1998) 1.10
The nuclear receptor PXR: a master regulator of "homeland" defense. Crit Rev Eukaryot Gene Expr (2002) 1.10
A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbeta. Pharm Res (2002) 1.10
A nuclear receptor-mediated xenobiotic response and its implication in drug metabolism and host protection. Curr Drug Metab (2003) 1.09
A phylogenetic survey of biliary lipids in vertebrates. J Lipid Res (2005) 1.08
Pregnane X receptor prevents hepatorenal toxicity from cholesterol metabolites. Proc Natl Acad Sci U S A (2005) 1.06
Genetic variants of PXR (NR1I2) and CAR (NR1I3) and their implications in drug metabolism and pharmacogenetics. Curr Drug Metab (2005) 1.04
Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein. Mol Pharmacol (2002) 1.04
Educating medical students in laboratory medicine: a proposed curriculum. Am J Clin Pathol (2010) 3.18
In silico repositioning of approved drugs for rare and neglected diseases. Drug Discov Today (2011) 1.45
Human pregnane X receptor antagonists and agonists define molecular requirements for different binding sites. Mol Pharmacol (2007) 1.39
POSITIVE TEST FOR ANTITHYROGLOBULIN ANTIBODIES DUE TO ADMINISTRATION OF IMMUNOGLOBULIN REPLACEMENT THERAPY IN A PATIENT WITH THYROID CANCER. Endocr Pract (2015) 1.38
Bile salts of vertebrates: structural variation and possible evolutionary significance. J Lipid Res (2009) 1.37
Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds. Curr Drug Metab (2006) 1.32
PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics. Pharmacogenomics (2008) 1.27
Notch1 co-opts lymphoid enhancer factor 1 for survival of murine T-cell lymphomas. Blood (2007) 1.18
The importance of discerning shape in molecular pharmacology. Trends Pharmacol Sci (2009) 1.17
Functional evolution of the vitamin D and pregnane X receptors. BMC Evol Biol (2007) 1.17
Evolution of pharmacologic specificity in the pregnane X receptor. BMC Evol Biol (2008) 1.14
Positive hepatitis B surface antigen tests due to recent vaccination: a persistent problem. BMC Clin Pathol (2012) 1.11
Elucidating the 'Jekyll and Hyde' nature of PXR: the case for discovering antagonists or allosteric antagonists. Pharm Res (2009) 1.09
Evolution of the bile salt nuclear receptor FXR in vertebrates. J Lipid Res (2008) 1.08
Ligand specificity and evolution of liver X receptors. J Steroid Biochem Mol Biol (2008) 1.06
Diversity of bile salts in fish and amphibians: evolution of a complex biochemical pathway. Physiol Biochem Zool (2010) 1.04
Challenges predicting ligand-receptor interactions of promiscuous proteins: the nuclear receptor PXR. PLoS Comput Biol (2009) 1.01
Machine learning methods and docking for predicting human pregnane X receptor activation. Chem Res Toxicol (2008) 0.99
Repression of the PDCD2 gene by BCL6 and the implications for the pathogenesis of human B and T cell lymphomas. Proc Natl Acad Sci U S A (2007) 0.98
A rapid analysis of plasma/serum ethylene and propylene glycol by headspace gas chromatography. Springerplus (2013) 0.95
Toxicology laboratory analysis and human exposure to p-chloroaniline. Clin Toxicol (Phila) (2009) 0.93
Drug monitoring: simultaneous analysis of lamotrigine, oxcarbazepine, 10-hydroxycarbazepine, and zonisamide by HPLC-UV and a rapid GC method using a nitrogen-phosphorus detector for levetiracetam. J Chromatogr Sci (2007) 0.92
Intrinsic disorder in nuclear hormone receptors. J Proteome Res (2008) 0.92
Resident training in clinical chemistry. Clin Lab Med (2007) 0.91
The evolution of farnesoid X, vitamin D, and pregnane X receptors: insights from the green-spotted pufferfish (Tetraodon nigriviridis) and other non-mammalian species. BMC Biochem (2011) 0.89
Molecular characterization of CYP2B6 substrates. Curr Drug Metab (2008) 0.88
Evolutionary diversity of bile salts in reptiles and mammals, including analysis of ancient human and extinct giant ground sloth coprolites. BMC Evol Biol (2010) 0.87
Microbial biotransformations of bile acids as detected by electrospray mass spectrometry. Adv Nutr (2013) 0.87
Analysis of vitamin D status at two academic medical centers and a national reference laboratory: result patterns vary by age, gender, season, and patient location. BMC Endocr Disord (2013) 0.82
Two farnesoid X receptor alpha isoforms in Japanese medaka (Oryzias latipes) are differentially activated in vitro. Aquat Toxicol (2010) 0.81
Extremely high myoglobin plasma concentrations producing hook effect in a critically ill patient. Clin Chim Acta (2012) 0.81
Understanding nuclear receptors using computational methods. Drug Discov Today (2009) 0.80
Evaluation of computational docking to identify pregnane X receptor agonists in the ToxCast database. Environ Health Perspect (2010) 0.80
Detection of neonatal drug exposure using umbilical cord tissue and liquid chromatography time-of-flight mass spectrometry. Ther Drug Monit (2014) 0.80
Simultaneous determination of lamotrigine, zonisamide, and carbamazepine in human plasma by high-performance liquid chromatography. Biomed Chromatogr (2007) 0.80
Functional constraints on the constitutive androstane receptor inferred from human sequence variation and cross-species comparisons. Hum Genomics (2005) 0.79
Major biliary bile acids of the medaka (Oryzias latipes): 25R- and 25S-epimers of 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoic acid. Zoolog Sci (2010) 0.79
Ligand- and structure-based pregnane X receptor models. Methods Mol Biol (2012) 0.78
Clinical effects and toxicokinetic evaluation following massive topiramate ingestion. J Med Toxicol (2010) 0.78
Unresolved discrepancies between cannabinoid test results for infant urine. Clin Chem (2012) 0.78
Activation of a tunicate (Ciona intestinalis) xenobiotic receptor orthologue by both natural toxins and synthetic toxicants. Toxicon (2011) 0.78
Laboratory diagnostic oversight committees and the profession of laboratory medicine. Am J Clin Pathol (2013) 0.77
COMPLEX EVOLUTION OF BILE SALTS IN BIRDS. Auk (2010) 0.77
A comparative study of the sulfation of bile acids and a bile alcohol by the Zebra danio (Danio rerio) and human cytosolic sulfotransferases (SULTs). J Steroid Biochem Mol Biol (2011) 0.75
Retrospective analysis of the diagnostic yield of newborn drug testing. BMC Pregnancy Childbirth (2014) 0.75
Chemical synthesis of the (25R)- and (25S)-epimers of 3α,7α,12α-trihydroxy-5α-cholestan-27-oic acid as well as their corresponding glycine and taurine conjugates. Chem Phys Lipids (2011) 0.75
Nonfatal tramadol overdose may cause false-positive phencyclidine on Emit-II assay. Am J Emerg Med (2012) 0.75
Impact of Endogenous and Exogenous Interferences on Clinical Chemistry Parameters Measured on Blood Gas Analyzers. Clin Lab (2017) 0.75
Therapeutic Drug Monitoring of Pentobarbital: Experience at an Academic Medical Center. Ther Drug Monit (2015) 0.75
Ordering of the Serum Angiotensin-Converting Enzyme Test in Patients Receiving Angiotensin-Converting Enzyme Inhibitor Therapy: An Avoidable but Common Error. Chest (2015) 0.75
Patterns of Drugs and Drug Metabolites Observed in Meconium: What Do They Mean? Ther Drug Monit (2015) 0.75